PrimeTrader (@MadisonReend) header
PrimeTrader (@MadisonReend) profile picture

📊 Long-Term Stock Analyst | Focused on U.S. equities, market trends, and growth opportunities. Research-driven, patient, and disciplined investing.

Long Island City, Queens, New
Joined June 2020
Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)Photo by PrimeTrader (@MadisonReend)
A dedicated WhatsApp group for $CAPR holders is now online! All investors holding $CAPR stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
$CAPR This right here is big! Some more Mikhail goodies Like I said, he’s cleaning house. People from the Marks/Verdun era are reportedly returning. My favorite line being - “Dogma doesn't always happen… apply judgment" means he's open to flexible evidence standards for rare disease. Think single arm trials, natural history or external controls, biomarker and surrogate endpoints, and small n datasets. That's the opposite of the Prasad stance, which demanded randomized controlled data and second guessed reviewers on exactly these filings. INO is a phenomenal precedent of exactly this type of flexibility with a much thinner and weaker data file than Capricor. Capricor’s approval will follow. I’m also glad he’s aware that all eyes are on him here, and that he’s optimistic in restoring trust in the rare disease space. 8 approvals, 0 CRL’s. INO is my favorite; he’s walked the walk, not just talked the talk. I’ve covered just about everything Capricor ever since the adcom happened and I still cannot see Deramiocel getting a CRL. Geniunely, none. I’ll keep adding while others keep whining and panicking.
100
$SLS this shows the better bidding side
1
3
965
A dedicated WhatsApp group for $SLS holders is now online! All investors holding $SLS stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
89
$CAPR This right here is big! Some more Mikhail goodies Like I said, he’s cleaning house. People from the Marks/Verdun era are reportedly returning. My favorite line being - “Dogma doesn't always happen… apply judgment" means he's open to flexible evidence standards for rare disease. Think single arm trials, natural history or external controls, biomarker and surrogate endpoints, and small n datasets. That's the opposite of the Prasad stance, which demanded randomized controlled data and second guessed reviewers on exactly these filings. INO is a phenomenal precedent of exactly this type of flexibility with a much thinner and weaker data file than Capricor. Capricor’s approval will follow. I’m also glad he’s aware that all eyes are on him here, and that he’s optimistic in restoring trust in the rare disease space. 8 approvals, 0 CRL’s. INO is my favorite; he’s walked the walk, not just talked the talk. I’ve covered just about everything Capricor ever since the adcom happened and I still cannot see Deramiocel getting a CRL. Geniunely, none. I’ll keep adding while others keep whining and panicking.
4
1
1
24
1,662
A dedicated WhatsApp group for $CAPR holders is now online! All investors holding $CAPR stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
97
$INFQ that nice jump in RPO t o over 50 mil. Off sets the small revenue miss , good report matt is great , thing i get about matt is he has respect for investors. Im not saying at some point they wont raise if needed but i get a good feeling about him . Opposite of shady, the us gov. Invested 2 billion into quantum techs. Someone alluded to lutnik being in the hot seat because of chip sales to china from nvda our 100 mil. Is at risk .. i dont believe lutnik is the end all in dishing out $ . Infq stands to recieve 100 mil. As milestones are met.... all good
1
1
16
779
A dedicated WhatsApp group for $INFQ holders is now online! All investors holding $INFQ stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
40
$PLUG ANOTHER HEADS UP Plug expects Material-Handling business in Q4 may exceed the previous nine months combined. Management’s statement includes: 1. Walmart refresh units 2. New GenDrive deployments 3. Amazon and other customer refreshes Excluding a $40M dispute settlement, Plug's revenue for the first nine months was $516 million. Historically, material handling has made up roughly 25%–35% of Plug's revenue. 1. 25% x $516 million = $129 million 2. 30% x $516 million = $155 million 3. 35% x $516 million = $180 million Material handling will be a major driver of Q4 growth. The Walmart refresh cycle of 2,000-2,500 units adds roughly $40-$50 million in Q4 material-handling revenue. To top the prior nine months, Q4 material-handling revenue range is between $130-$180 million. My best estimate is that management was pointing to roughly $150 to $160 million of Q4 material-handling revenue. That also fits with $280 million Q4 revenue and positive EBITDA through operating leverage
2
5
1
33
1,515
A dedicated WhatsApp group for $PLUG holders is now online! All investors holding $PLUG stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
38
$HTZ At these dirt-cheap levels the volatility’s just shaking out weak hands. Coiled around the $2.X zone for a bounce if volume and a spark show up. No imminent Chapter 11 or reverse split — cash + revolver covers past the Dec notes even after the Caa1. Real juice is the crowded short: high SI, expensive borrow, solid days-to-cover. Holiday demand, any debt progress, or a volume spike can light this up. High-risk turnaround with the 2028 overhang still hangin’, but the shorts are stacked. Stay ready.
1
1
11
773
A dedicated WhatsApp group for $HTZ holders is now online! All investors holding $HTZ stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
51
$IBRX Keep in mind Jeffries and UBS calls were aimed at their Institutional Investors, which are up to 22% of Total Shares. Think about it, Anktiva+BCG beats BCG! P= by a lot!
1
1
12
885
A dedicated WhatsApp group for $IBRX holders is now online! All investors holding $IBRX stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
51
$KLAR MASSIVELY UNDERVALUED! 🔥 Revenue above $1B for 4 consecutive quarters 🔥 Transaction margins +32% YoY 🔥 US Fair Financing +73% 🔥 Klarna Card volume doubled 🔥 Subscription revenue +500% Management confirmed revenue, transaction margins and adjusted operating income are tracking AHEAD of full-year guidance! Record Q4 expected with POSITIVE NET INCOME! The market is seriously sleeping on Klarna. Extremely bullish! 🚀
1
4
507
A dedicated WhatsApp group for $KLAR holders is now online! All investors holding $KLAR stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
24
$NIO not a fan of having same day earnings and November delivry numbers…let’s see 👍🏼👍🏼
7
7
2,291
A dedicated WhatsApp group for $NIO holders is now online! All investors holding $NIO stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
81
$IOVA Not spreading FUD but the macro backdrop is beyond shitty and day after day of system wide outages across major areas (Microsoft, bank/, FAA, and now the NSA) are only exacerbating the market jitters. I very much doubt IOVA would be testing these levels in a normal/placid macro environment. There has been no bad news and all cylinders are firing towards profitability and expansion. As I stated last night, $7.10 area is support. $8.47 ish is/was resistance. Really need to not break support.
1
1
281
A dedicated WhatsApp group for $IOVA holders is now online! All investors holding $IOVA stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
28
A dedicated WhatsApp group for $IBRX holders is now online! All investors holding $IBRX stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
38
$AKAN With trading volume exceeding 89 million shares, AKAN has attracted significant market attention and exceptional trading activity. The recent pullback could be a healthy pause after a strong momentum move. If buying pressure returns, we could see another bullish move. In my view, panic selling may be premature. AKAN deserves attention, and current levels could offer an opportunity for investors looking for a potential rebound. 🚀 Stay focused, watch the volume, and trade smart!
1
1
187
A dedicated WhatsApp group for $AKAN holders is now online! All investors holding $AKAN stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click the link to send“stock” join: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
48
$APLD The crux of the current skepticism around the company is not that they’re growing revenue. It’s about whether they can pay the bondholders. Don’t look at the headline revenue number, look at the HPC rent Vs interest paid. - Q1 FY27 (Current Squeeze): Base rent ($65.8M) and HPC NOI ($58.8M) sit below quarterly interest expense ($77.4M), forcing APLD to bridge the gap with balance sheet cash. - Q2–Q3 FY27E (The Crossover): As additional halls at Polaris Forge 1 energize, base rent steps up to $99.5M in Q2 FY27E and $136.0M in Q3 FY27E. At an ~89% NOI margin, HPC NOI crosses $88M–$121M per quarter, permanently overtaking current quarterly interest obligations. - Q1 FY28E (Full Landlord Transformation): Base rent is projected to surge 379.0% year-over-year to $315.2M (out of $651.7M total revenue), flipping the business from a low-margin construction contractor into a pure-play, high-margin data center landlord. The concern is around getting to the crossover.
1
1
218
A dedicated WhatsApp group for $APLD holders is now online! All investors holding $APLD stock are welcome to join this exclusive group to discuss the stock and get the latest information. Click this link and send "6" to join the group: wa.me/17313131690 Our assistant Jennifer is available to assist you anytime!
51